A total of 435 clinical isolates of anaerobes were tested with a broth microdilution method to determine the activity of BAY y 3118 compared with those of other agents against anaerobic bacteria. All strains ofBacteroides capilosus, PrevoteUa spp., Porphyromonas spp., Fusobacterium spp., Clostridium spp., Eubacterium spp., Peptostreptococcus spp., and VeiloneUa parvula were susceptible (MICs of -2 ,ug/ml) to BAY y 3118. Against the 315 strains of the Bacteroidesfragilis group, five strains required elevated MICs (.4 ,ug/ml) of BAYy 3118. Only imipenem and metronidazole were active against all anaerobes. Overall, BAY y 3118 was more active than ciprofloxacin, sparfloxacin, piperacillin, cefotaxime, and clindamycin against the test isolates.
Mich.) within a dilution range of 0.02 to 256 jig/ml. When more fastidious anaerobes, including Porphyromonas, Fusobacterium, Veillonella, and some Prevotella species, were tested, the test medium was supplemented with 3% lysed horse blood. The inoculum was prepared by suspending growth from 24-h blood agar plates to a no. 1 McFarland standard and dilution to a final inoculum of 105 CFU per well (106 CFU/ml). All plates were incubated in an anaerobic chamber (10% C02, 10% H2, 80% N2) for 48 h at 37°C and read. The 
